Daily Current Affairs / DCGI approves two clinical trials of indigenous Covid vaccine Corbevax
Category : National Published on: September 04 2021
· The Drug Controller General of India- DCGI has approved two clinical trials of indigenous Covid vaccine Corbevax.
· Vaccine maker Biologicals E has received permission for Phase II and III trials on children between the ages of five and eighteen under certain conditions.
· The Department of Biotechnology and its PSU Biotechnology Industry Research Assistance Council – BIRAC have provided support to Biologicals E's COVID-19 Vaccine.
· This support will be provided from the preclinical phase to the third phase of the trial.
Important facts
About the DCGI
v DCGI: Drugs Controller General of India
v Headquarters location: New Delhi
India's household debt rises to 23.9% of GDP in FY25, signaling post-pandemic financial stress.
Read More....PM Modi distributes over 51,000 appointment letters at 15th Rozgar Mela across 47 locations.
Read More....India and Bhutan hold the 6th Joint Group of Customs Meeting in Thimphu on April 24–25, 2025.
Read More....Cheetah Nirva gives birth to five cubs at Kuno, raising India’s cheetah count to 31.
Read More....Indian companies send goods worth ₹85,000 crore annually to Pakistan via Dubai, Singapore, bypassing restrictions.
Read More....India signs agreement with France for 26 Rafale-Marine aircraft for Navy.
Read More....Delhi launches ₹10 lakh free health cover under Ayushman Vay Vandana for citizens aged 70+.
Read More....Karnataka-based humanitarian Madhusudan Sai receives Fiji’s highest civilian award.
Read More....President Droupadi Murmu confers Padma Awards to 71 achievers, including Shekhar Kapur and R. Ashwin.
Read More....Start-up ‘Sarvam’ to build India’s first AI large language model under ₹10,370 crore IndiaAI Mission.
Read More....
